Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Alafenamide

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandDoseManufacturer
GenvoyaAUCAESEUGBMXTWUS150 mg / 200 mg / 10 mg / 90 mg / 120 mg / 6 mgGilead Sciences Ireland Unlimited Company
Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tabletsESGB150 mg / 200 mg / 10 mg / 90 mg / 120 mg / 6 mgGilead Sciences Ireland Unlimited Company
elvitegravir + cobicistat + emtricitabina + tenofovir alafenamidaES150 mg / 200 mg / 10 mgGilead Sciences Ireland Unlimited Company
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamideUS150 mg / 200 mg / 10 mgGilead Sciences, Inc.
tenofovir alafenamide + emtricitabine + elvitegravir + cobicistatAU10 mg / 200 mg / 150 mgGilead Sciences Pty Limited
elvitegravir + cobicistat + tenofovir alafenamide fumarate + emtricitabine + tenofovir alafenamideAU——
捷扶康 膜衣錠TW—香港商吉立亞醫藥有限公司台灣分公司
GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tabletsAU11.2 mg / 200 mg / 150 mgGilead Sciences Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.